Kairos Pharma (KAPA) Invested Capital (2024)
Kairos Pharma's (KAPA) quarterly Invested Capital came in at $4.1 million in Q3 2024.
Powered by 
Analysis
Kairos Pharma (KAPA) Invested Capital (2024) Analysis & Trends
Kairos Pharma (KAPA) has reported Invested Capital for 1 consecutive years, with $4.1 million the latest figure, recorded in Q3 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.58 Bn | 192.59 Bn | 7.24 Bn | 74.44 Bn |
| 2 | Gilead Sciences | 180.17 Bn | 176.99 Bn | 6.22 Bn | 40.49 Bn |
| 3 | Vertex Pharmaceuticals | 130.59 Bn | 122.74 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.61 Bn | 73.61 Bn | 3.93 Bn | 33.70 Bn |
| 5 | Argenx Se | 60.24 Bn | 55.05 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.29 Bn | 49.15 Bn | 52.00 Mn | 7.35 Bn |
| 7 | Alnylam Pharmaceuticals | 32.96 Bn | 29.65 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.94 Bn | 30.66 Bn | 1.96 Bn | 26.94 Bn |
| 9 | Roivant Sciences | 29.38 Bn | 29.38 Bn | 1.16 Mn | - |
| 10 | Kairos Pharma | 30.41 Mn | 25.07 Mn | - | - |